en

PRODUCT DETAIL

Ambrisentan Mylan 5 mg filmom obalené tablety

Code 2085D
MA number EU/1/19/1368/001
Product Form: tbl flm 30x5 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KX Antihypertensives for pulmonary arterial hypertension
C02KX02 Ambrisentan
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 20.06.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.04.2024
eu-flag.png sk-flag.png